Breaking News

AtomVie Closes Series A Financing with Avego

Will expand its current clinical GMP manufacturing capacity of radiopharmaceutical products to include commercial stage production.

Author Image

By: Charlie Sternberg

Associate Editor

Global CDMO AtomVie Global Radiopharma Inc. has successfully closed its Series A financing with Avego Management LLC, a healthcare investment firm. The company has received a financing commitment of at least $40 million.   AtomVie is a spinout from the CPDC (Centre for Probe Development and Commercialization), and within CPDC, the CMO business unit, now AtomVie, served as the GMP manufacturer and supplier of finished-dose therapeutic radiopharmaceuticals for the past seven years. AtomVie will ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters